This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Memorial University of Newfoundland directory, so their courses may be missing. Find their university profile.
Research
Latest papers
“Where do I go from here?” Navigating a lifelong road without a map: the care experiences of hereditary cancer patients
European Journal of Human Genetics · 2026
Canadian consensus for the assessment and testing of Lynch syndrome.
Journal of medical genetics · 2025
Exploring family communication preferences in hereditary breast and ovarian cancer and Lynch syndrome: a national Canadian survey.
Journal of community genetics · 2024
Latest funding
- $10,000
Gynecologic Cancer Impact Accelerator
CIHR · 2023 · Co-investigator
- $10,000
Convening a gynecologic cancer patient advisory group to adapt a digital health tool
CIHR · 2022 · Co-investigator
- $879,750
Digital self-tracking and self-testing for early detection of endometrial cancer
CIHR · 2022 · Co-investigator
17 publications.
“Where do I go from here?” Navigating a lifelong road without a map: the care experiences of hereditary cancer patients
Butkowsky C, Carroll JC, Aronson M, Sam J, Reble E, Clausen M, Gopalakrishnan R, Sparkes B, Rajeziesfahani S, Aguda V
Canadian consensus for the assessment and testing of Lynch syndrome.
Aronson M, Palma L, Semotiuk K, Nuk J, Pollett A, Singh H, Rothenmund H, Racher H, Jessen J, Pautler SE, Rusnak A, Rutka M, Etchegary H, Tiano T, Kaurah P, Dawson L, Hawrysh A, Ward T, Bedard A, Sheffield BS, Lerner-Ellis J, Jacob K, Ferguson S, Kim CA, Chamberlain E, Dornan K, Waldman L, Holter S, Horte J, Hyde A, Kwon J, MacMillan A, O'Loughlin M, Tabori U, Gallinger S, Kim R
Exploring family communication preferences in hereditary breast and ovarian cancer and Lynch syndrome: a national Canadian survey.
Burke K, Dawson L, Hodgkinson K, Wilson BJ, Etchegary H
"I just wanted more": Hereditary cancer syndromes patients' perspectives on the utility of circulating tumour DNA testing for cancer screening.
Adi-Wauran E, Clausen M, Shickh S, Gagliardi AR, Denburg A, Oldfield LE, Sam J, Reble E, Krishnapillai S, Regier DA, Baxter NN, Dawson L, Penney LS, Foulkes W, Basik M, Sun S, Schrader KA, Karsan A, Pollett A, Pugh TJ, CHARM consortium, Kim RH, Bombard Y
“Should I Let Them Know I Have This?”: Multifaceted Genetic Discrimination and Limited Awareness of Legal Protections among Individuals with Hereditary Cancer Syndromes
Gopalakrishnan R, Sam J, Butkowsky C, Reble E, Clausen M, Rajeziesfahani S, Sparkes B, Aguda V, Aronson M, Bishop D
Beyond Sterilization: A Comprehensive Review on the Safety and Efficacy of Opportunistic Salpingectomy as a Preventative Strategy for Ovarian Cancer.
Zadabedini Masouleh T, Etchegary H, Hodgkinson K, Wilson BJ, Dawson L
Specialty Care and Counselling about Hereditary Cancer Risk Improves Adherence to Cancer Screening and Prevention in Newfoundland and Labrador Patients with BRCA1/2 Pathogenic Variants: A Population-Based Retrospective Cohort Study.
Roebothan A, Smith KN, Seal M, Etchegary H, Dawson L
Current and new frontiers in hereditary cancer surveillance: Opportunities for liquid biopsy.
Farncombe KM, Wong D, Norman ML, Oldfield LE, Sobotka JA, Basik M, Bombard Y, Carile V, Dawson L, Foulkes WD, Malkin D, Karsan A, Parkin P, Penney LS, Pollett A, Schrader KA, Pugh TJ, Kim RH, CHARM consortium
Cancer prevention in cancer predisposition syndromes: A protocol for testing the feasibility of building a hereditary cancer research registry and nurse navigator follow up model.
Etchegary H, Pike A, Puddester R, Watkins K, Warren M, Francis V, Woods M, Green J, Savas S, Seal M, Gao Z, Avery S, Curtis F, McGrath J, MacDonald D, Burry TN, Dawson L
Bone health after RRBSO among BRCA1/2 mutation carriers: a population-based study.
do Valle HA, Kaur P, Kwon JS, Cheifetz R, Dawson L, Hanley GE
Gynecologic Cancer Impact Accelerator
Principal investigators: Mcalpine, Jessica N
Keywords: Cancer Care Delivery; Ethnicity; Genetic Testing; Gynecologic Cancer; Health Equity; Knowledge Mobilization; Molecular Classification; Precision Oncology; Prevention; Race
Convening a gynecologic cancer patient advisory group to adapt a digital health tool
Principal investigators: Brotto, Lori Anne
Keywords: Advisory Group; Digital Health; Gynecologic Cancer; Sexual Desire; Sexual Health; Survivors
Digital self-tracking and self-testing for early detection of endometrial cancer
Principal investigators: Talhouk, Aline; Anglesio, Michael S; Hill, Janet E; Money, Deborah M; Tinker, Anna
Keywords: Biomarkers; Digital Health; Early Detection; Endometrial Cancer; Health Equity; Predictive Modelling; Risk Prediction; Self-Tracking; Wearables; Women'S Health
Toward equity in cancer genetics: identifying racial disparities in cancer genetics services
Principal investigators: Bombard, Yvonne
Keywords: Chart Review; Equity; Genetics Health Services; Health Disparities; Healthcare Access; Racialized Communities
Variations in care for hereditary cancer syndrome families: direct and indirect socio-economic impacts
Principal investigators: Bombard, Yvonne; Sun, Sophie; Etchegary, Holly; Schrader, Kasmintan A
Keywords: Genetic Testing; Genomic Sequencing; Hereditary Cancer; Indirect Impacts Of Disease
Cancer prevention in cancer predisposition syndromes: Testing the feasibility of building a hereditary cancer research registry and nurse navigator follow up model
Principal investigators: Etchegary, Holly; Dawson, Lesa M
Keywords: Brca 1/2; Hereditary Cancers; Inherited Cancer Registry; Lynch Syndrome; Model Of Inherited Cancer Care; Nurse Navigator
Digital self-tracking for early detection and prevention of endometrial cancer during reproductive aging
Principal investigators: Talhouk, Aline; Anglesio, Michael S; Hill, Janet E; Money, Deborah M; Tinker, Anna
Keywords: Biomarkers; Digital Health; Early Detection; Endometrial Cancer; Female Health; Health Equity; Predictive Modelling; Risk Prediction; Self-Tracking; Wearables
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Pediatrics
- Family Medicine
- Institute of Health Policy, Management, and Evaluation
- Genome Sciences Centre
- Social Studies of Medicine
- Oncology
- Genetics
- Other
Co-authors at Memorial University of Newfoundland, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Holly Etchegary
Family Medicine
10 shared papers, latest 2026
Yvonne Bombard
Institute of Health Policy, Management, and Evaluation
5 shared papers, latest 2026
Aaron Pollett
Faculty
4 shared papers, latest 2025
Aly Karsan
Genome Sciences Centre
3 shared papers, latest 2024
Mark Basik
Social Studies of Medicine
3 shared papers, latest 2024
Sevtap Savas
Faculty
2 shared papers, latest 2024
Petros Pechlivanoglou
Pediatrics
2 shared papers, latest 2026
Andrea Eisen
Faculty
2 shared papers, latest 2026
William Foulkes
Lady Davis Institute for Medical Research
2 shared papers, latest 2024
Kasmintan Schrader
Genetics
2 shared papers, latest 2026
Andrea Eisen
Oncology
2 shared papers, latest 2026
Jennifer Nuk
Faculty
1 shared papers, latest 2025
Harminder Singh
Biology
1 shared papers, latest 2025
Steven Gallinger
Medical Biophysics
1 shared papers, latest 2025
David Malkin
Pediatrics
1 shared papers, latest 2023
Maria Mathews
Community Health
1 shared papers, latest 2009
Mike Warren
Medicine
1 shared papers, latest 2022
Sam Ratnam
Pathology & Molecular Medicine
1 shared papers, latest 2015
Marshall Godwin
Family Medicine
1 shared papers, latest 2015
Harminder Singh
Community Health Sciences
1 shared papers, latest 2025
Raymond Kim
Department of Medicine
1 shared papers, latest 2025
Uri Tabori
Genetics and Genome Biology
1 shared papers, latest 2025
Zhiwei Gao
Community Health
1 shared papers, latest 2022
Patricia Parkin
Pediatrics
1 shared papers, latest 2023
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.